Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →David StolzenbergD.O.
Physical Medicine and Rehabilitation · Bryn Mawr, PA 19010
NPI: 1003050535
8
🟢 Low
🤖 ML Fraud Detection Score: Very High
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
1,311
Total Claims
$23K
Drug Cost
420
Beneficiaries
$54
Cost/Patient
Risk Score Breakdown 8/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,404 Physical Medicine and Rehabilitation providers
+3%
Opioid rate vs peers
20.9% vs 20.2% avg
-88%
Cost per patient vs peers
$54 vs $455 avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Our machine learning model — trained on 281 confirmed fraud cases — gives this provider a "Very High" fraud-pattern score. All 20 decision trees in our ensemble model agree that this provider's prescribing patterns resemble those of confirmed fraud cases. This is a statistical finding, not an accusation.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
20.9%
Opioid Rate
274
Opioid Claims
$8,632
Opioid Cost
9.9%
Long-Acting Rate
This provider's opioid prescribing rate of 20.9% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 0 claims · $0
Generic: 1,304 claims · $21K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Buprenorphine | 27 | $7,025 |
| Gabapentin | 407 | $5,226 |
| Celecoxib | 87 | $2,343 |
| Tizanidine Hcl | 150 | $2,141 |
| Pregabalin | 48 | $1,023 |
| Methocarbamol | 55 | $761 |
| Methylprednisolone | 67 | $687 |
| Tramadol Hcl | 94 | $507 |
| Meloxicam | 86 | $492 |
| Hydrocodone/Acetaminophen | 41 | $433 |
| Oxycodone Hcl/Acetaminophen | 63 | $348 |
| Acetaminophen With Codeine | 38 | $270 |
| Baclofen | 16 | $204 |
| Topiramate | 23 | $153 |
| Prednisone | 47 | $136 |
Prescribing Profile
16
Unique Drugs
8.0
Anomaly Score
Patient Profile
74
Avg Age
62%
Female
1.00
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About